Prenatal diagnosis versus first-trimester screening of trisomy 21 among pregnant women aged 35 or more

References

• Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007;110:687–94
   PubMed Web of Science ®Google Scholar
• Loane M, Morris JK, Addor MC, Arriola L, et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet 2013;21:27–33
   PubMed Web of Science ®Google Scholar
• Avgidou K, Papageorghiou A, Bindra R, et al. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol 2005;192:1761–7
   PubMed Web of Science ®Google Scholar
• Dey M, Sharma S, Aggarwal S. Prenatal screening methods for aneuploidies. N Am J Med Sci 2013;5:182–90
   Google Scholar
• Wright D, Spencer K, Kagan K K, et al. First-trimester combined screening for trisomy 21 at 7--14 weeks' gestation. Ultrasound Obstet Gynecol 2010;36:404–11
   PubMed Web of Science ®Google Scholar
• Boyd P, Garne E; EUROCAT Working Group. Special Report: prenatal screening policies in Europe. EUROCAT Central Registry, University of Ulster; 2010
   Google Scholar
• Ekelund CK, Jørgensen FS, Petersen OB, et al. Danish Fetal Medicine Research Group. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. Br Med J 2008;337:a2547
   PubMed Web of Science ®Google Scholar
• Decreto Legge 10 settembre 1998. Aggiornamento del decreto ministeriale 6 marzo 1995 concernente l'aggiornamento del decreto ministeriale 14 Aprile 1984 recante protocolli di accesso agli esami di laboratorio e di diagnostica strumentale per le donne in stato di gravidanza ed a tutela della maternità. Gazzetta Ufficiale n.245 1998
   Google Scholar
• ACOG Committee on Practice Bullettins-Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetricians-gynecologists. Number 55, September 2004 (replaces practice pattern number 6, October 1997). Management of Post-term Pregnancy. Obstet Gynecol 2004;104:639–46
   Google Scholar
• Spencer K, Spencer CE, Power M, et al. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003;110:281–6
   PubMed Web of Science ®Google Scholar
• Pandya PP, Santiago C, Snijders RJ, Nicolaides KH. First trimester fetal nuchal translucency. Curr Opin Obstet Gynecol 1995;7:95–102
   PubMed Web of Science ®Google Scholar
• Simonsen TS, Sørensen S, Ekelund C, Jørgensen FS. Danish Fetal Medicine Research Group. Prenatal characteristics of false negative cases from first-trimester screening of Down syndrome (trisomy 21). Prenat Diagn 2013;33:400–2
   PubMed Web of Science ®Google Scholar
• Engels MA, Twisk JW, Blankenstein MA, van Vugt JM. Age independent first trimester screening for Down syndrome: improvement in test performance. Prenat Diagn 2013;33:884–8
   PubMed Web of Science ®Google Scholar
• Chasen ST, McCullough LB, Chervenak F. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population? Am J Obstet Gynecol 2004;190:769–74
   PubMedGoogle Scholar
• ACOG Committee on Practice Bullettins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217–27
   Google Scholar
• Nakata N, Wang Y, Bhatt S. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat Diagn 2010;30:198–206
   PubMed Web of Science ®Google Scholar
• Chitayat D, Langlois S, Wilson RD; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for fetal aneuploidy in singleton pregnancies. J Obstet Gynaecol Can 2011;33:736–50
   PubMedGoogle Scholar
• Ayräs O, Tikkanen M, Eronen M, et al. Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenat Diagn 2013;33:856–62
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Chervenak FA, McCullough LB, et al. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005;193:322–6
   PubMed Web of Science ®Google Scholar
• Spencer K. Aneuploidy screening in the first trimester. Am J Med Genet C Semin Med Genet 2007;145C:18–32
   PubMed Web of Science ®Google Scholar
• Kagan KO, Wright D, Baker A, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31:618–24
   PubMed Web of Science ®Google Scholar